StonvexLoading…
StonvexStonvexStonvexCore line items from NWN's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
Quarterly filings sourced directly from SEC EDGAR. Real-time earnings actuals are in the Earnings panel above.
| Metric | Annual 2025 2025-12-31 | Annual 2024 2024-12-31 | Annual 2023 2023-12-31 | Annual 2022 2022-12-31 |
|---|---|---|---|---|
Revenue | $1.21B | $1.12B | $1.17B | $1.04B |
Operating Income | $280.89M | $191.14M | $184.94M | $167.48M |
Net Income | $113.32M | $78.87M | $93.87M | $86.30M |
EPS (Diluted) | $2.77 | $2.03 | $2.59 | $2.54 |
Total Assets | $6.17B | $5.23B | $4.87B | $4.75B |
Total Liabilities | Not available | Not available | Not available | Not available |
Cash & Equivalents | $36.67M | $38.49M | $32.92M | $29.27M |
Free Cash Flow OCF − CapEx | $-197.77M | $-194.12M | $-47.40M | $-190.93M |
Shares Outstanding | 41.56M | 40.22M | 37.63M | 35.52M |